Eliana R Meza-Miranda1,2, Oriol A Rangel-Zúñiga1,2, Carmen Marín1,2, Pablo Pérez-Martínez1,2, Javier Delgado-Lista1,2, Carmen Haro1,2, Patricia Peña-Orihuela1,2, Ana I Jiménez-Morales1,2, María M Malagón2,3, Francisco J Tinahones2,4, José López-Miranda1,2, Francisco Pérez-Jiménez1,2, Antonio Camargo5,6. 1. Lipids and Atherosclerosis Unit, IMIBIC/Reina Sofia University Hospital/University of Cordoba, Av. Menendez Pidal, s/n., 14004, Cordoba, Spain. 2. CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. 3. Department of Cell Biology, Physiology, and Immunology, IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain. 4. Endocrinology and Nutrition Service, Hospital Virgen de la Victoria, Malaga, Spain. 5. Lipids and Atherosclerosis Unit, IMIBIC/Reina Sofia University Hospital/University of Cordoba, Av. Menendez Pidal, s/n., 14004, Cordoba, Spain. antonio.camargo@imibic.org. 6. CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. antonio.camargo@imibic.org.
Abstract
PURPOSE: Previous studies have shown the anti-inflammatory and antioxidant properties of phenolic compounds of virgin olive oil (VOO). However, the effect of bioavailable phenolic compounds on the vascular endothelium is unknown. We aimed to evaluate the effect of the consumption of virgin olive oil rich in phenolic compounds on the vascular endothelium. METHODS: We treated HUVEC with human serum obtained in fasting state and after the intake of a breakfast prepared with VOO with a high or low content of phenolic compounds. RESULTS: Treatment of HUVEC with serum obtained 2 h after the intake of the high-phenol VOO-based breakfast decreased p65 and MCP-1 gene expression (p < 0.001 and p = 0.002, respectively) and increased MT-CYB, SDHA and SOD1 gene expression (p = 0.004, p = 0.012 and p = 0.001, respectively), as compared with the treatment of HUVEC with the serum obtained 2 h after the intake of the low-phenol VOO-based breakfast. The treatment with serum obtained 4 h after the intake of the high-phenol VOO-based breakfast decreased MCP-1 and CAT gene expression (p < 0.001 and p = 0.003, respectively) and increased MT-CYB gene expression (p < 0.001), as compared to the treatment with serum obtained 4 h after the intake of the low-phenol VOO-based breakfast. CONCLUSION: Our results suggest that the consumption of virgin olive oil rich in phenolic compounds may reduce the risk of atherosclerosis development by decreasing inflammation and improving the antioxidant profile in the vascular endothelium.
PURPOSE: Previous studies have shown the anti-inflammatory and antioxidant properties of phenolic compounds of virgin olive oil (VOO). However, the effect of bioavailable phenolic compounds on the vascular endothelium is unknown. We aimed to evaluate the effect of the consumption of virgin olive oil rich in phenolic compounds on the vascular endothelium. METHODS: We treated HUVEC with human serum obtained in fasting state and after the intake of a breakfast prepared with VOO with a high or low content of phenolic compounds. RESULTS: Treatment of HUVEC with serum obtained 2 h after the intake of the high-phenolVOO-based breakfast decreased p65 and MCP-1 gene expression (p < 0.001 and p = 0.002, respectively) and increased MT-CYB, SDHA and SOD1 gene expression (p = 0.004, p = 0.012 and p = 0.001, respectively), as compared with the treatment of HUVEC with the serum obtained 2 h after the intake of the low-phenolVOO-based breakfast. The treatment with serum obtained 4 h after the intake of the high-phenolVOO-based breakfast decreased MCP-1 and CAT gene expression (p < 0.001 and p = 0.003, respectively) and increased MT-CYB gene expression (p < 0.001), as compared to the treatment with serum obtained 4 h after the intake of the low-phenolVOO-based breakfast. CONCLUSION: Our results suggest that the consumption of virgin olive oil rich in phenolic compounds may reduce the risk of atherosclerosis development by decreasing inflammation and improving the antioxidant profile in the vascular endothelium.
Authors: Ana I Jiménez-Morales; Juan Ruano; Javier Delgado-Lista; Juan M Fernandez; Antonio Camargo; Fernando López-Segura; Javier Caballero Villarraso; Francisco Fuentes-Jiménez; Jose López-Miranda; Francisco Pérez-Jiménez Journal: J Clin Endocrinol Metab Date: 2011-08-03 Impact factor: 5.958
Authors: Juan Ruano; Jose Lopez-Miranda; Francisco Fuentes; Juan A Moreno; Cecilia Bellido; Pablo Perez-Martinez; Aquiles Lozano; Purificación Gómez; Yolanda Jiménez; Francisco Pérez Jiménez Journal: J Am Coll Cardiol Date: 2005-10-24 Impact factor: 24.094
Authors: Antonio Camargo; Javier Delgado-Lista; Antonio Garcia-Rios; Cristina Cruz-Teno; Elena M Yubero-Serrano; Pablo Perez-Martinez; Francisco M Gutierrez-Mariscal; Pilar Lora-Aguilar; Fernando Rodriguez-Cantalejo; Francisco Fuentes-Jimenez; Francisco Jose Tinahones; Maria M Malagon; Francisco Perez-Jimenez; Jose Lopez-Miranda Journal: Br J Nutr Date: 2011-11-15 Impact factor: 3.718
Authors: María-Isabel Covas; Kristiina Nyyssönen; Henrik E Poulsen; Jari Kaikkonen; Hans-Joachim F Zunft; Holger Kiesewetter; Antonio Gaddi; Rafael de la Torre; Jaakko Mursu; Hans Bäumler; Simona Nascetti; Jukka T Salonen; Montserrat Fitó; Jyrki Virtanen; Jaume Marrugat Journal: Ann Intern Med Date: 2006-09-05 Impact factor: 25.391
Authors: Paola Ditano-Vázquez; José David Torres-Peña; Francisco Galeano-Valle; Ana Isabel Pérez-Caballero; Pablo Demelo-Rodríguez; José Lopez-Miranda; Niki Katsiki; Javier Delgado-Lista; Luis A Alvarez-Sala-Walther Journal: Nutrients Date: 2019-11-19 Impact factor: 5.717